Comparative pharmacology of bipolar disorder and schizophrenia
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 39 (2) , 153-158
- https://doi.org/10.1016/s0920-9964(99)00115-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 ExpressionJournal of Biological Chemistry, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- Transcranial Magnetic Stimulation in Mania: A Controlled StudyAmerican Journal of Psychiatry, 1998
- Clozapine in bipolar disorder: treatment implications for other atypical antipsychoticsJournal of Affective Disorders, 1998
- Mood Improvement Following Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in Patients With Depression: A Placebo-Controlled Crossover TrialAmerican Journal of Psychiatry, 1997
- Induction of Mania by Risperidone Resistant to Mood StabilizersJournal of Clinical Psychopharmacology, 1997
- The Glutamatergic Dysfunction Hypothesis for SchizophreniaHarvard Review of Psychiatry, 1996
- Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depressionNeuroReport, 1995
- Open Trial of a Calcium Antagonist, Nimodipine, in Acute ManiaClinical Neuropharmacology, 1990
- Flupenthixol decanoate in recurrent manic‐depressive illnessActa Psychiatrica Scandinavica, 1981